Metropolis Capital Ltd lowered its position in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 3.0% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 882,944 shares of the company’s stock after selling 27,620 shares during the period. HCA Healthcare comprises about 10.4% of Metropolis Capital Ltd’s portfolio, making the stock its 2nd biggest position. Metropolis Capital Ltd owned about 0.41% of HCA Healthcare worth $376,788,000 at the end of the most recent reporting period.
Other large investors have also recently bought and sold shares of the company. Sunbelt Securities Inc. grew its stake in shares of HCA Healthcare by 171.7% in the 1st quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock valued at $2,954,000 after buying an additional 3,945 shares during the period. Sei Investments Co. lifted its holdings in shares of HCA Healthcare by 27.5% in the 1st quarter. Sei Investments Co. now owns 467,796 shares of the company’s stock worth $221,380,000 after purchasing an additional 100,764 shares in the last quarter. SEB Asset Management AB bought a new position in shares of HCA Healthcare in the first quarter valued at $75,534,000. OP Asset Management Ltd bought a new position in HCA Healthcare in the 1st quarter valued at about $12,883,000. Finally, Darsana Capital Partners LP boosted its stake in HCA Healthcare by 46.7% during the 2nd quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock valued at $428,879,000 after purchasing an additional 350,000 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.
HCA Healthcare Stock Up 1.9%
HCA Healthcare stock traded up $8.73 during mid-day trading on Tuesday, reaching $463.61. 597,550 shares of the company’s stock were exchanged, compared to its average volume of 1,335,850. The business’s fifty day simple moving average is $427.22 and its 200 day simple moving average is $418.81. HCA Healthcare, Inc. has a one year low of $353.99 and a one year high of $556.52. The firm has a market capitalization of $100.37 billion, a PE ratio of 15.53, a P/E/G ratio of 1.55 and a beta of 1.10.
HCA Healthcare (NYSE:HCA – Get Free Report) last announced its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%. The firm had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. During the same quarter in the prior year, the company earned $6.84 EPS. The business’s revenue for the quarter was up 8.7% on a year-over-year basis. On average, sell-side analysts forecast that HCA Healthcare, Inc. will post 29.45 earnings per share for the current year.
HCA Healthcare Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th were given a dividend of $0.78 per share. The ex-dividend date was Wednesday, September 16th. This represents a $3.12 annualized dividend and a yield of 0.7%. HCA Healthcare’s dividend payout ratio is presently 10.45%.
Analysts Set New Price Targets
Several analysts have recently commented on HCA shares. KeyCorp lowered their price objective on HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating for the company in a research note on Monday, July 27th. Oppenheimer decreased their price target on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a report on Monday, July 27th. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research report on Friday, October 2nd. TD Cowen raised their price objective on HCA Healthcare from $431.00 to $460.00 and gave the company a “buy” rating in a research note on Monday, October 12th. Finally, Jefferies Financial Group set a $450.00 price objective on shares of HCA Healthcare in a report on Tuesday, July 14th. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $467.61.
Read Our Latest Stock Analysis on HCA Healthcare
More HCA Healthcare News
Here are the key news stories impacting HCA Healthcare this week:
- Positive Sentiment: HCA was highlighted as a strong momentum stock by Zacks, suggesting favorable recent price and trading trends may continue to attract momentum-oriented investors. Here’s Why HCA Healthcare Is a Strong Momentum Stock
- Positive Sentiment: Zacks also identified HCA as a top long-term stock based on its earnings outlook and potential to outperform, reinforcing the longer-term bullish case. Why HCA Healthcare Is a Top Stock for the Long-Term
- Positive Sentiment: HCA’s TriStar Centennial plans to invest $90 million in women’s and children’s services, a move that could strengthen its regional healthcare franchise and support future capacity and revenue growth. HCA’s TriStar Centennial to Invest $90 Million
- Neutral Sentiment: Twenty-four analysts reportedly have a consensus target of $467.61, indicating limited additional upside relative to the current trading level and no major change in Wall Street sentiment. HCA Healthcare Analyst Consensus Target
- Neutral Sentiment: The HCA Healthcare Foundation awarded $25,000 to a Virginia youth mental-wellness program. The announcement supports community relations but is unlikely to materially affect near-term financial results. HCA Healthcare Foundation Award
- Negative Sentiment: Zacks expects HCA to report a year-over-year earnings decline and says the company lacks the key factors that typically support an earnings beat. This is the most important near-term risk ahead of Tuesday’s report and could pressure the stock if results or guidance disappoint. Analysts Estimate HCA Healthcare to Report a Decline in Earnings
HCA Healthcare Company Profile
HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.
The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.
Featured Articles
- Five stocks we like better than HCA Healthcare
- Meta Platforms’ AI Comeback Faces an Earnings Test—And a $10 Billion Charge
- IonQ’s Bold Expansion Could Leave Shareholders Paying the Price
- Powering Up: Applied Digital Execs Buy $6.7M in Stock
- Chip Stocks Are Sliding—Why Is Smart Money Buying?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
